Skip to content
Catalyst

O-acetyl-(R)-carnitineFinding

O-acetyl-(R)-carnitine decreases interleukin‑6 concentration

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“After three days of the treatment protocol, also the serum levels of TNF- α, IL-6, and ICAM-1, as proinflammatory cytokines, decreased more in the ALC group than in the placebo group (p value = 0.04, 0.02, and 0.03, respectively).”
Quoted verbatim from Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.
This finding among the 92 findings on its endpoint

O-acetyl-(R)-carnitine

Interleukin-6 concentration

lowers

Who
Adults with first-ever acute ischaemic stroke, onset under 24 hours, not candidates for reperfusion therapy, all receiving standard care; change over the 3-day treatment
Dose studied
1000 mg oral ALC three times per day for three consecutive days (nine doses); nasogastric tube if dysphagia

Moderate evidencePMID 35936217 · 2022

02 · The study

Study
RCT
Duration
3 days

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7MMMZD3C4NAHB7BJC86R8W8